New vaccine aims to tame hepatitis b without lifelong drugs
NCT ID NCT04684914
First seen Jan 10, 2026 · Last updated May 14, 2026 · Updated 24 times
Summary
This study tested a vaccine called HepTcell in 87 adults with inactive chronic hepatitis B who had low levels of the virus. The goal was to see if the vaccine could lower hepatitis B surface antigen (HBsAg) or clear it from the blood. The study was stopped early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATITIS B, CHRONIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Central Sooner Research
Oklahoma City, Oklahoma, 73071, United States
-
Consorcio Hospital General Universitario De Valencia
Valencia, 46014, Spain
-
Goethe University Hospital
Frankfurt am Main, 60590, Germany
-
Hospital Clínic De Barcelona
Barcelona, 08028, Spain
-
Hospital Nuestra Señora De Valme
Seville, 41014, Spain
-
Hospital Universitari I Politècnic La Fe
Valencia, 46026, Spain
-
Hospital Universitari Vall D'Hebron
Barcelona, 08035, Spain
-
Hospital Universitario La Paz
Madrid, 28046, Spain
-
Kansas City Research Institute
Kansas City, Missouri, 64131, United States
-
Paragon Rx Clinical
Garden Grove, California, 92840, United States
-
Queens Medical Center
Nottingham, NG7 2UH, United Kingdom
-
San Jose Gastroenterology Institute
San Jose, California, 95128, United States
-
St. Georges University of London
London, SW17 0RE, United Kingdom
-
St. Mary's Hospital
London, W2 1NY, United Kingdom
-
Stanford University Department of Medicine
Redwood City, California, 94063, United States
-
The Ottawa Hospital
Ottawa, Ontario, K1H 8L6, Canada
-
Toronto Centre for Liver Disease (TCLD), Toronto General Hospital, UHN
Toronto, Ontario, M5G 2C4, Canada
-
Toronto Liver Centre
Toronto, Ontario, M6H 3M1, Canada
-
University of Alberta Hospital
Edmonton, Alberta, T6G 2G3, Canada
-
University of Calgary Liver Unit - Heritage Medical Research Clinic
Calgary, Alberta, T2N 4Z6, Canada
-
Univesritätsklinikum Hamburg-Eppendorf
Hamburg, 20246, Germany
Conditions
Explore the condition pages connected to this study.